Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 5/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27849982 | 0.97 | MCL1 (0.46) | MCL1ALDH1A1KMT2AKDM4EMEN1 | |
| Cyclopentane SCHEMBL29109135 | 0.92 | MCL1 (0.42) | MCL1ALDH1A1KMT2AKDM4EMEN1 | |
| SCHEMBL21224223 | 0.89 | MCL1 (0.43) | MCL1ALDH1A1KMT2AMEN1 | |
| SCHEMBL776027 | 0.87 | MCL1 (0.39) | MCL1 | |
| Fluoroacetate SCHEMBL28406186 | 0.85 | MCL1 (0.37) | MCL1 | |
| Propiolic Acid SCHEMBL29034656 | 0.85 | MCL1 (0.37) | MCL1 | |
| SCHEMBL8133533 | 0.84 | — | — | |
| SCHEMBL433293 | 0.84 | — | — | |
| Acrylic Acid SCHEMBL25407941 | 0.83 | LMNA (0.43) | MCL1ALDH1A1KMT2AMEN1LMNA | |
| Trifluoroacetic Acid SCHEMBL21226529 | 0.83 | MCL1 (0.36) | MCL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 255 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119008954-A | Additive for positive electrode slurry of lithium ion battery, positive electrode slurry, positive electrode plate and lithium ion battery | 广东金晟新能源股份有限公司 | 2024-11-22 | — | — | CN | claimed |
| WO-2020132057-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH ANHYDRIDE CONTAINING ELECTROLYTE ADDITIVES | ENEVATE CORPORATION (US) | 2020-06-25 | — | — | WO | claimed |
| US-20200203711-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH ANHYDRIDE CONTAINING ELECTROLYTE ADDITIVES | ENEVATE CORPORATION | 2020-06-25 | — | — | US | claimed |
| US-8927759-B2 | Method for producing 2-cyanoacetic acid anhydride and further reaction products thereof | Henkel IP & Holding GmbH (DE) | 2015-01-06 | — | — | US | claimed |
| EP-2420486-B1 | Method for producing 2-cyanoacetic acid anhydride and further reaction products thereof | HENKEL IRELAND LTD (DE) | 2013-11-06 | — | — | EP | claimed |
| US-20130131370-A1 | METHOD FOR PRODUCING 2-CYANOACETIC ACID ANHYDRIDE AND FURTHER REACTION PRODUCTS THEREOF | Loctite (R&D) Limited Ltd. (IE) | 2013-05-23 | — | — | US | claimed |
| EP-2420486-A1 | Method for producing 2-cyanoacetic acid anhydride and further reaction products thereof | Loctite (R & D) Limited (IE) | 2012-02-22 | — | — | EP | claimed |
| WO-2012010472-A1 | METHOD FOR PRODUCING 2-CYANOACETIC ACID ANHYDRIDE AND FURTHER REACTION PRODUCTS THEREOF | LOCTITE (R & D) LTD. (IE) | 2012-01-26 | — | — | WO | claimed |
| JP-55069136-A | — | — | None | — | — | JP | disclosed |
| US-12620622-B2 | Compound including sulfur-containing heterocyclic cation and bis(oxolato)borate anion, electrolytic solution and electrochemical device including the same | DAIKIN INDUSTRIES, LTD. (JP) | 2026-05-05 | — | — | US | disclosed |
| US-20250260063-A1 | ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, SECONDARY BATTERY, AND LITHIUM-ION SECONDARY BATTERY | DAIKIN INDUSTRIES, LTD. (JP) | 2025-08-14 | — | — | US | disclosed |
| EP-3780232-B1 | ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, LITHIUM-ION SECONDARY BATTERY, AND MODULE | DAIKIN IND LTD (JP) | 2025-07-30 | — | — | EP | disclosed |
| CN-120077502-A | Electrolyte, electrochemical device, secondary battery, and lithium ion secondary battery | 大金工业株式会社 | 2025-05-30 | — | — | CN | disclosed |
| US-20250174720-A1 | ELECTROLYTE, ELECTROCHEMICAL DEVICE, LITHIUM ION SECONDARY BATTERY, AND MODULE | DAIKIN INDUSTRIES, LTD. (JP) | 2025-05-29 | — | — | US | disclosed |
| EP-0105919-A1 | 1-CARBOXYALKANOYLPERHYDROINDOLE-2-CARBOXYLIC ACIDS AND DERIVATIVES. | CIBA GEIGY AG (CH) | 1984-04-25 | — | — | EP | disclosed |
| WO-1983003828-A1 | 1-CARBOXYALKANOYLPERHYDROINDOLE-2-CARBOXYLIC ACIDS AND DERIVATIVES | CIBA-GEIGY AG (CH) | 1983-11-10 | — | — | WO | disclosed |
| US-4401818-A | HYPOTENSIVE AGENTS, CARDIOACTIVE AGENTS | CIBA-GEIGY CORPORATION (US) | 1983-08-30 | — | — | US | disclosed |
| US-4390700-A | HYPOTENSIVE AGENTS, CARDIOVASCULAR DISORDERS | CIBA-GEIGY CORPORATION (US) | 1983-06-28 | — | — | US | disclosed |
| US-4374847-A | HYPOTENSIVE AGENTS | CIBA-GEIGY CORPORATION (US) | 1983-02-22 | — | — | US | disclosed |
| JP-S5569136-A | SILVER HALIDE PHOTOGRAPHIC MATERIAL CONTAINING LOW MOLECULAR WEIGHT ACYLATED GELATIN | FUJI PHOTO FILM CO LTD | 1980-05-24 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130131370-A1 | METHOD FOR PRODUCING 2-CYANOACETIC ACID ANHYDRIDE AND FURTHER REACTION PRODUCTS THEREOF | PCCA, CA2, COASY | MCL1 4404/4885ALDH1A1 642/4885KMT2A 638/4885 |
| US-20250174720-A1 | ELECTROLYTE, ELECTROCHEMICAL DEVICE, LITHIUM ION SECONDARY BATTERY, AND MODULE | HCN2, HCN1, HCN3 | MCL1 3443/4885ALDH1A1 955/4885KMT2A 2412/4885 |
| US-12620622-B2 | Compound including sulfur-containing heterocyclic cation and bis(oxolato)borate anion, electrolytic solution and electrochemical device including the same | ASH2L, OLA1, ODC1 | MCL1 2724/4885ALDH1A1 1584/4885KMT2A 831/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.